CAPITOLO III:
BIBLIOGRAFIA
1. Simpson, E.R., Sources of estrogen and their importance. J Steroid Biochem Mol Biol, 2003. 86(3-5): p. 225-30.
2. Lonning, P.E., et al., Recent data on intratumor estrogens in breast cancer. Steroids, 2011. 76(8): p. 786-91.
3. Savolainen-Peltonen, H., et al., Breast adipose tissue estrogen metabolism in postmenopausal women with or without breast cancer. J Clin Endocrinol Metab, 2014.
99(12): p. E2661-7.
4. D'Ascenzo, G., et al., Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities. Sci Total Environ, 2003. 302(1-3): p. 199-209.
5. Samavat, H. and M.S. Kurzer, Estrogen metabolism and breast cancer. Cancer Lett, 2015. 356(2 Pt A): p. 231-43.
6. Menasce, L.P., et al., Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics, 1993.
17(1): p. 263-5.
7. Enmark, E., et al., Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab, 1997. 82(12): p. 4258-65. 8. Kvingedal, A.M. and E.B. Smeland, A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue. FEBS Lett, 1997. 407(1): p. 59-62.
9. Roforth, M.M., et al., Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing. PLoS One, 2014. 9(4): p. e95987.
10. Cummings SR, B.D., Rubin SM, Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. Internal medicine Journal, 1989. 149(11): p. 2445-8.
11. RE, H., Regulation of neuropeptide gene expression by steroid hormones. Molecular Neurobiology, 1988. 2(3): p. 183-200.
12. McEwen BS, W.C., Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Experimental Gerontology, 1994.
29: p. 431–436.
13. Garcia-Segura, L.M., I. Azcoitia, and L.L. DonCarlos, Neuroprotection by estradiol. Prog Neurobiol, 2001. 63(1): p. 29-60.
14. Sortino, M.A., et al., Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology, 2004. 145(11): p. 5080-6.
15. Raval, A.P., H. Bramlett, and M.A. Perez-Pinzon, Estrogen preconditioning protects the hippocampal CA1 against ischemia. Neuroscience, 2006. 141(4): p. 1721-1730.
16. Sarvari, M., et al., Estradiol replacement alters expression of genes related to neurotransmission and immune surveillance in the frontal cortex of middle-aged, ovariectomized rats. Endocrinology, 2010. 151(8): p. 3847-62.
17. Dubal, D.B., et al., Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A, 2001. 98(4): p. 1952-7. 18. Balthazart, J. and G.F. Ball, Is brain estradiol a hormone or a neurotransmitter? Trends Neurosci, 2006. 29(5): p. 241-9.
19. Fink, G., et al., Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol, 1996. 16(3): p. 325-44.
20. Toran-Allerand, C.D., The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci, 1996. 18(1-2): p. 36-48.
21. Humphreys, G.I., Y.S. Ziegler, and A.M. Nardulli, 17beta-estradiol modulates gene expression in the female mouse cerebral cortex. PLoS One, 2014. 9(11): p. e111975.
22. Lee, A.S., et al., Gender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDL. Cardiovasc Diabetol, 2014. 13: p. 64.
23. Shah, S., et al., A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. Int J Pediatr Endocrinol, 2014. 2014(1): p. 12.
24. Liu, Z., et al., Estradiol improves cardiovascular function through up-regulation of SOD2 on vascular wall. Redox Biol, 2014. 3: p. 88-99.
25. Bouris, P., et al., Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells. Matrix Biol, 2015. 43: p. 42-60.
26. Zhang, F., H. Kang, and Q. Xu, Estrogen increases secretion of stromal cell derived factor-1 in human breast cancer cells. Int J Clin Exp Med, 2014. 7(12): p. 5529-34.
27. D'Agostino, R.B., Sr., et al., Cardiovascular Disease Risk Assessment: Insights from Framingham. Glob Heart, 2013. 8(1): p. 11-23.
28. Menotti, A. and P.E. Puddu, How the Seven Countries Study contributed to the definition and development of the Mediterranean diet concept: a 50-year journey. Nutr Metab Cardiovasc Dis, 2015. 25(3): p. 245-52.
29. Group, M.R.F.I.T.R., Multiple Risk Factors Intervention Trial: risk factor changes and Mortality results. The Journal of American Medical Association, 1982. 248(12): p. 1465-1477.
30. Cecilia P Chung, J.T.G., Richard A Kronmal, Wendy S Post, Allan C Gelber, Michelle Petri, Moyses Szklo, Robert Detrano, Matthew J Budoff, Roger S Blumenthal, Pamela Ouyang, David Bush and a.J.M. Bathon, Progression of coronary artery atherosclerosis in rheumatoid arthritis comparison with participants from the Multi-Ethnic Study of Atherosclerosis. Arthritis Research & Therapy, 2013. 15.
31. Salmon, J.E. and M.J. Roman, Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management. Current Opinion in Rheumatology, 2001. 13(5): p. 341-344.
32. Franch-Nadal, J., et al., Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study. Int J Endocrinol, 2014. 2014: p. 131709.
33. Solimene, M.C., Coronary heart disease in women: a challenge for the 21st century. Clinics (Sao Paulo), 2010. 65(1): p. 99-106.
34. Patrick Vallance, N.C., Endothelial function and nitric oxide: clinical relevance. . Heart, 2001. 85: p. 342–350.
35. Douglas, G. and K.M. Channon, The pathogenesis of atherosclerosis. Medicine, 2010. 38(8): p. 397-402.
36. Galkina, E. and K. Ley, Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol, 2009. 27: p. 165-97.
37. Ignarro LJ, C.G., Casini A, Napoli C., Nitric oxide as a signaling molecule in the vascular system: an overview. Journal of Cardiovascular Pharmacology, 1999. 34(6): p. 879-886.
38. Quillon, A., B. Fromy, and R. Debret, Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: a review of nervous and biomechanical signals. Nitric Oxide, 2015. 45: p. 20-6.
39. Fumihiko Kamezaki, M.T., Masao Takahashi, Shinjo Sonoda, Tatsuhiko Kubo, Yoshihisa Fujino, Tetsuo Adachi, Haruhiko Abe, Masaaki Takeuchi, Toshihiko Mayumi, Yutaka Otsuji, Plasma Levels of Nitric Oxide Metabolites Are Markedly Reduced in Normotensive Men With Electrocardiographically Determined Left Ventricular Hypertrophy. Hypertension, 2014. 64: p. 516-522.
40. Tsutsui, M., et al., Significance of nitric oxide synthases: Lessons from triple nitric oxide synthases null mice. J Pharmacol Sci, 2015. 127(1): p. 42-52.
41. Morishita, T., et al., Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Natl Acad Sci U S A, 2005. 102(30): p. 10616-21.
42. Kadowaki, T., et al., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest, 2006. 116(7): p. 1784-92.
43. Matsuzawa, Y., et al., Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol, 2004. 24(1): p. 29-33.
44. Shioji, K., et al., Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention. Circ J, 2007. 71(5): p. 675-80.
45. Ortiz PA, G.J., Cardiovascular ancd renal control in NOS-deficient mouse models. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 2003. 284(3): p. 628-638.
46. Visser, M. and H.J. Coelingh Bennink, Clinical applications for estetrol. J Steroid Biochem Mol Biol, 2009. 114(1-2): p. 85-9.
47. Visser, M., J.M. Foidart, and H.J. Coelingh Bennink, In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism. Climacteric, 2008. 11
Suppl 1: p. 64-8.
48. Holinka, C.F., E. Diczfalusy, and H.J. Coelingh Bennink, Estetrol: a unique steroid in human pregnancy. J Steroid Biochem Mol Biol, 2008. 110(1-2): p. 138-43.
49. Coelingh Bennink, F., et al., Maternal and fetal estetrol levels during pregnancy. Climacteric, 2008. 11 Suppl 1: p. 69-72.
50. McKenna, N.J. and B.W. O'Malley, Nuclear receptors, coregulators, ligands, and selective receptor modulators: making sense of the patchwork quilt. Ann N Y Acad Sci, 2001. 949: p. 3-5.
51. Vasudevan, N. and D.W. Pfaff, Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocr Rev, 2007. 28(1): p. 1-19.
52. Kundu, N., et al., Sequential determination of serum human placental lactogen, estriol, and estetrol for assessment of fetal morbidity. Obstet Gynecol, 1978. 52(5): p. 513-20.
53. Coelingh Bennink, H.J., et al., Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model. Climacteric, 2008. 11 Suppl 1: p. 2-14.
54. Abot, A., et al., The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor alpha modulation, uncoupling nuclear and membrane activation. EMBO Mol Med, 2014. 6(10): p. 1328-46.
55. Heegaard, A.M., et al., Estrogenic uterovaginal effects of oral estetrol in the modified Allen-Doisy test. Climacteric, 2008. 11 Suppl 1: p. 22-8.
56. Beral, V., E. Banks, and G. Reeves, Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet, 2002. 360(9337): p. 942-4.
57. The Writing Group for the Women's Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama, 2002. 288(3): p. 321-33.
58. Katovich, M.J. and J. O'Meara, Effect of chronic estrogen on the skin temperature response to naloxone in morphine-dependent rats. Can J Physiol Pharmacol, 1987. 65(4): p. 563-7.
59. Holinka, C.F., M. Brincat, and H.J. Coelingh Bennink, Preventive effect of oral estetrol in a menopausal hot flush model. Climacteric, 2008. 11 Suppl 1: p. 15-21.
60. Jozan, S., B. Kreitmann, and F. Bayard, Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue culture. Acta Endocrinol (Copenh), 1981. 98(1): p. 73-80.
61. Coelingh, B.H.J.T., et al., Estetrol, a pregnancy-specific human steroid, prevents and suppresses mammary tumor growth in a rat model. Climacteric, 2008. 11(1): p. 29-29.
62. Giretti, M.S., et al., Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton. Front Endocrinol, 2014. 5: p. 80.
63. Gerard, C., et al., Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms. Oncotarget, 2015.
64. Pluchino, N., et al., Effect of estetrol administration on brain and serum allopregnanolone in intact and ovariectomized rats. J Steroid Biochem Mol Biol, 2014. 143: p. 285-90.
65. Pluchino, N., et al., Effect of estetrol on Beta-Endorphin level in female rats. Steroids, 2015. 95C: p. 104-110.
66. Hilgers, R.H., et al., Vasorelaxing effects of estetrol in rat arteries. J Endocrinol, 2012. 215(1): p. 97-106.
67. Nussler, A.K., et al., Fluorometric measurement of nitrite/nitrate by 2,3-diaminonaphthalene. Nat Protoc, 2006. 1(5): p. 2223-6.
68. Chambliss, K.L. and P.W. Shaul, Estrogen Modulation of Endothelial Nitric Oxide Synthase. Endocr Rev, 2002. 23(5): p. 665-686.
69. Simoncini, T., et al., Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause, 2005. 12(1): p. 69-77.
70. Fu, X.D. and T. Simoncini, Non-genomic sex steroid actions in the vascular system. Semin Reprod Med, 2007. 25(3): p. 178-86.
71. Haynes, M.P., et al., Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res, 2000. 87(8): p. 677-82.
72. Dimmeler, S., et al., Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature, 1999. 399(6736): p. 601-5.
73. Fulton, D., et al., Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature, 1999. 399(6736): p. 597-601.
74. Hisamoto, K., et al., Estrogen Induces the Akt-dependent Activation of Endothelial Nitric- oxide Synthase in Vascular Endothelial Cells. J Biol Chem, 2001. 276(5): p. 3459-3467.
75. Herrera, E.A., et al., The placental pursuit for an adequate oxidant balance between the mother and the fetus. Front Pharmacol, 2014. 5: p. 149.
76. Murphy, V.E., et al., Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev, 2006. 27(2): p. 141-69.
77. Poston, L., et al., Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am J Clin Nutr, 2011. 94(6 Suppl): p. 1980S-1985S.
78. Hillman, N.H., S.G. Kallapur, and A.H. Jobe, Physiology of transition from intrauterine to extrauterine life. Clin Perinatol, 2012. 39(4): p. 769-83.
79. Gerard, C., et al., Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation. J Endocrinol, 2015. 224(1): p. 85-95.
80. Mendelsohn, M.E. and R.H. Karas, The protective effects of estrogen on the cardiovascular system. N Engl J Med, 1999. 340(23): p. 1801-11.
81. Genazzani, A.R. and T. Simoncini, Pharmacotherapy: Benefits of menopausal hormone therapy--timing is key. Nat Rev Endocrinol, 2013. 9(1): p. 5-6.
82. Simoncini, T., et al., Tibolone activates nitric oxide synthesis in human endothelial cells. J Clin Endocrinol Metab, 2004. 89(9): p. 4594-600.
83. Simoncini, T., A.R. Genazzani, and J.K. Liao, Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation, 2002. 105(11): p. 1368-73.
84. Simoncini, T., et al., Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology, 2002. 143(6): p. 2052-61.
85. Simoncini, T., et al., Estrogen-like effects of wine extracts on nitric oxide synthesis in human endothelial cells. Maturitas, 2011. 70(2): p. 169-75.
86. Simoncini, T., et al., Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature, 2000. 407(6803): p. 538-41.
